Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Bluestone

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantationM G Levisetti, P A Padrid, G L Szot, et al.
Science (New York, N.Y.)|December 12, 1986
Characterization of T cell receptor gamma chain expression in a subset of murine thymocytesA M Lew, D M Pardoll, W L Maloy, et al.
Transplantation|August 25, 1999
Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis)B R Theriault, J R Thistlethwaite, M G Levisetti, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumabA M Posselt, M D Bellin, M Tavakol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152)M D Griffin, D K Hong, P O Holman, et al.
Cellular Immunology|March 16, 2000
In vitro characterization of five humanized OKT3 effector function variant antibodiesD Xu, M L Alegre, S S Varga, et al.
Diabetologia|October 23, 2012
Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trialK C Herold, S E Gitelman, S M Willi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 5, 2017
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney TransplantsS Chandran, Q Tang, M Sarwal, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
The Extra-Islet Pancreas Supports Autoimmunity in Human Type 1 DiabetesG L Barlow, C M Schürch, S S Bhate, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2013
Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantationA L Putnam, N Safinia, A Medvec, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantationM G Levisetti, P A Padrid, G L Szot, et al.
Science (New York, N.Y.)|December 12, 1986
Characterization of T cell receptor gamma chain expression in a subset of murine thymocytesA M Lew, D M Pardoll, W L Maloy, et al.
Transplantation|August 25, 1999
Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis)B R Theriault, J R Thistlethwaite, M G Levisetti, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 28, 2010
Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumabA M Posselt, M D Bellin, M Tavakol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152)M D Griffin, D K Hong, P O Holman, et al.
Cellular Immunology|March 16, 2000
In vitro characterization of five humanized OKT3 effector function variant antibodiesD Xu, M L Alegre, S S Varga, et al.
Diabetologia|October 23, 2012
Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trialK C Herold, S E Gitelman, S M Willi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 5, 2017
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney TransplantsS Chandran, Q Tang, M Sarwal, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
The Extra-Islet Pancreas Supports Autoimmunity in Human Type 1 DiabetesG L Barlow, C M Schürch, S S Bhate, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2013
Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantationA L Putnam, N Safinia, A Medvec, et al.
Pageof 24